Gut Microbiota Diets Found to Improve Efficacy of Anti-Diabetic Drugs, New Study Shows
27th November, Hyderabad 2024: A first-of-its-kind clinical trial in India shows remarkable results for people with diabetes. The trial was conducted using BugSpeaks, a flagship technology of Leucine Rich Bio, India’s first microbiome-based company. BugSpeaks is a gut microbiome profiling test that provides nutritional recommendations based on the individual’s gut microbiota profile. With India being […]
Gut Microbiota Diets Found to Improve Efficacy of Anti-Diabetic Drugs, New Study Shows Read More »
